| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 1.63e-08 | 10 | 61 | 4 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 1.63e-08 | 10 | 61 | 4 | GO:0005391 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC9A9 SLC25A21 SLC9A2 ATP7B SLC41A3 SLC17A1 SLC37A2 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 1.81e-08 | 477 | 61 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 2.39e-08 | 301 | 61 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 2.56e-08 | 11 | 61 | 4 | GO:0008556 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.91e-08 | 171 | 61 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.89e-08 | 36 | 61 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.89e-08 | 36 | 61 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | antigen binding | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 HLA-DRA IGHV3-30-3 IGHV3-43D | 1.11e-07 | 190 | 61 | 8 | GO:0003823 |
| GeneOntologyMolecularFunction | steroid hormone binding | 9.41e-07 | 7 | 61 | 3 | GO:1990239 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.27e-06 | 62 | 61 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | antiporter activity | 3.97e-06 | 138 | 61 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 | 1.10e-05 | 465 | 61 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.19e-05 | 167 | 61 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 SLC37A2 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 1.62e-05 | 758 | 61 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 1.85e-05 | 627 | 61 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.06e-05 | 109 | 61 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 3.01e-05 | 664 | 61 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.22e-05 | 296 | 61 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC9A9 SLC25A21 SLC9A2 ATP7B SLC41A3 SLC17A1 SLC37A2 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC7A10 SLC47A2 | 4.62e-05 | 1180 | 61 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC9A9 SLC25A21 SLC9A2 ATP7B SLC41A3 SLC17A1 SLC37A2 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC7A10 SLC47A2 | 1.14e-04 | 1289 | 61 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 1.32e-04 | 161 | 61 | 5 | GO:0051087 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 1.33e-04 | 793 | 61 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | acetyl-CoA C-acetyltransferase activity | 1.37e-04 | 6 | 61 | 2 | GO:0003985 | |
| GeneOntologyMolecularFunction | C-acetyltransferase activity | 1.91e-04 | 7 | 61 | 2 | GO:0016453 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acyltransferase activity | 1.91e-04 | 7 | 61 | 2 | GO:0003988 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.11e-04 | 178 | 61 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 2.54e-04 | 8 | 61 | 2 | GO:0000253 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 3.07e-04 | 43 | 61 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | carbonyl reductase (NADPH) activity | 3.26e-04 | 9 | 61 | 2 | GO:0004090 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.81e-04 | 441 | 61 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.35e-04 | 614 | 61 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 5.70e-04 | 53 | 61 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 6.15e-04 | 127 | 61 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 8.16e-04 | 14 | 61 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | potassium ion binding | 8.16e-04 | 14 | 61 | 2 | GO:0030955 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 8.16e-04 | 14 | 61 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | sodium ion binding | 8.16e-04 | 14 | 61 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 8.40e-04 | 138 | 61 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 9.40e-04 | 15 | 61 | 2 | GO:0052650 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.07e-03 | 16 | 61 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.52e-03 | 19 | 61 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 1.86e-03 | 21 | 61 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.37e-03 | 775 | 61 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 2.43e-03 | 24 | 61 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.85e-03 | 26 | 61 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 3.07e-03 | 27 | 61 | 2 | GO:0008106 | |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 3.07e-03 | 27 | 61 | 2 | GO:0047617 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 3.07e-03 | 27 | 61 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 3.30e-03 | 28 | 61 | 2 | GO:0016289 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 3.78e-03 | 30 | 61 | 2 | GO:0018455 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 3.85e-03 | 839 | 61 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hormone binding | 3.86e-03 | 103 | 61 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 3.88e-03 | 840 | 61 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.88e-03 | 840 | 61 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 3.97e-03 | 104 | 61 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 4.29e-03 | 32 | 61 | 2 | GO:0004033 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 5.71e-03 | 37 | 61 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 6.04e-03 | 238 | 61 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 7.85e-03 | 133 | 61 | 3 | GO:0008528 | |
| GeneOntologyMolecularFunction | steroid binding | 7.85e-03 | 133 | 61 | 3 | GO:0005496 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 9.03e-03 | 140 | 61 | 3 | GO:0001653 | |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 9.08e-03 | 47 | 61 | 2 | GO:0016790 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 9.46e-03 | 48 | 61 | 2 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.27e-02 | 56 | 61 | 2 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1.45e-02 | 60 | 61 | 2 | GO:0016655 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.54e-02 | 62 | 61 | 2 | GO:0003678 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 1.96e-08 | 11 | 59 | 4 | GO:0010248 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 HLA-DRA IGHV3-30-3 C5 IGHV3-43D | 2.13e-08 | 235 | 59 | 9 | GO:0016064 |
| GeneOntologyBiologicalProcess | B cell mediated immunity | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 HLA-DRA IGHV3-30-3 C5 IGHV3-43D | 2.94e-08 | 244 | 59 | 9 | GO:0019724 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.33e-07 | 208 | 59 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 1.40e-07 | 17 | 59 | 4 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 1.40e-07 | 17 | 59 | 4 | GO:0036376 | |
| GeneOntologyBiologicalProcess | response to glycoside | 2.21e-07 | 5 | 59 | 3 | GO:1903416 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 2.33e-07 | 91 | 59 | 6 | GO:0140115 | |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 5.43e-07 | 170 | 59 | 7 | GO:1902600 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.11e-06 | 275 | 59 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 1.57e-06 | 30 | 59 | 4 | GO:0006883 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 3.20e-06 | 142 | 59 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 3.20e-06 | 142 | 59 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 3.72e-06 | 37 | 59 | 4 | GO:0055075 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 HLA-DRA IGHV3-30-3 C5 IGHV3-43D | 4.85e-06 | 449 | 59 | 9 | GO:0002449 |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 HLA-DRA IGHV3-30-3 C5 IGHV3-43D | 6.11e-06 | 462 | 59 | 9 | GO:0002460 |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 1.36e-05 | 51 | 59 | 4 | GO:1990573 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 1.36e-05 | 51 | 59 | 4 | GO:0055078 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 HLA-DRA IGHV3-30-3 C5 IGHV3-43D | 3.51e-05 | 576 | 59 | 9 | GO:0002443 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 4.95e-05 | 230 | 59 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 5.20e-05 | 232 | 59 | 6 | GO:0071805 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 5.52e-05 | 26 | 59 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 1.25e-04 | 272 | 59 | 6 | GO:0006813 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 SLC37A2 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 1.26e-04 | 1017 | 59 | 11 | GO:0098660 |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.36e-04 | 35 | 59 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 1.65e-04 | 705 | 59 | 9 | GO:0055080 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 1.87e-04 | 717 | 59 | 9 | GO:0050801 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 2.60e-04 | 922 | 59 | 10 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 3.08e-04 | 942 | 59 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 3.32e-04 | 611 | 59 | 8 | GO:0030003 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 3.74e-04 | 622 | 59 | 8 | GO:0006873 | |
| GeneOntologyBiologicalProcess | regulation of pH | 3.87e-04 | 120 | 59 | 4 | GO:0006885 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 NMUR1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 TG | 4.36e-04 | 1374 | 59 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | adaptive immune response | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 HLA-DRA IGHV3-30-3 C5 IGHV3-43D | 5.86e-04 | 838 | 59 | 9 | GO:0002250 |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 6.45e-04 | 59 | 59 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | immune effector process | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 HLA-DRA IGHV3-30-3 C5 IGHV3-43D | 6.99e-04 | 859 | 59 | 9 | GO:0002252 |
| GeneOntologyBiologicalProcess | chemical homeostasis | CA12 CCN4 SLC9A9 SLC9A2 ATP7B ASGR2 PKHD1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 | 7.31e-04 | 1249 | 59 | 11 | GO:0048878 |
| GeneOntologyBiologicalProcess | phosphate ion transmembrane transport | 8.25e-04 | 15 | 59 | 2 | GO:0035435 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid metabolic process | 9.41e-04 | 16 | 59 | 2 | GO:0019852 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 1.08e-03 | 272 | 59 | 5 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 1.08e-03 | 272 | 59 | 5 | GO:0046395 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 1.14e-03 | 1115 | 59 | 10 | GO:0034220 |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 1.26e-03 | 421 | 59 | 6 | GO:0044282 | |
| GeneOntologyBiologicalProcess | lactone metabolic process | 1.33e-03 | 19 | 59 | 2 | GO:1901334 | |
| GeneOntologyBiologicalProcess | estrous cycle | 1.48e-03 | 20 | 59 | 2 | GO:0044849 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC9A9 SLC9A2 ATP7B SLC41A3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC47A2 | 1.51e-03 | 1157 | 59 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | relaxation of cardiac muscle | 1.63e-03 | 21 | 59 | 2 | GO:0055119 | |
| GeneOntologyBiologicalProcess | response to potassium ion | 1.63e-03 | 21 | 59 | 2 | GO:0035864 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.63e-03 | 21 | 59 | 2 | GO:0042574 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.76e-03 | 180 | 59 | 4 | GO:0015698 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 3.19e-08 | 12 | 61 | 4 | GO:0005890 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 IGHV3-30-3 IGHV3-43D | 5.34e-07 | 166 | 61 | 7 | GO:0019814 |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 1.26e-05 | 49 | 61 | 4 | GO:0090533 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 2.00e-05 | 55 | 61 | 4 | GO:0098533 | |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 5.01e-05 | 4 | 61 | 2 | GO:0060342 | |
| HumanPheno | Episodic quadriplegia | 1.78e-05 | 2 | 22 | 2 | HP:0200072 | |
| Domain | P-type_ATPase_IIC | 7.37e-10 | 6 | 51 | 4 | IPR005775 | |
| Domain | - | 2.36e-08 | 32 | 51 | 5 | 3.40.1110.10 | |
| Domain | - | 2.36e-08 | 32 | 51 | 5 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 3.79e-08 | 35 | 51 | 5 | IPR023299 | |
| Domain | P_typ_ATPase | 4.39e-08 | 36 | 51 | 5 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 4.39e-08 | 36 | 51 | 5 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 4.39e-08 | 36 | 51 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 5.07e-08 | 37 | 51 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 5.07e-08 | 37 | 51 | 5 | PF00122 | |
| Domain | HAD-like_dom | 7.31e-08 | 79 | 51 | 6 | IPR023214 | |
| Domain | - | 8.76e-08 | 16 | 51 | 4 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 8.76e-08 | 16 | 51 | 4 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.14e-07 | 17 | 51 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.14e-07 | 17 | 51 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 1.47e-07 | 18 | 51 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 1.47e-07 | 18 | 51 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.85e-07 | 19 | 51 | 4 | IPR004014 | |
| Domain | Thiolase_AS | 7.27e-05 | 5 | 51 | 2 | IPR020610 | |
| Domain | Thiolase_acyl_enz_int_AS | 7.27e-05 | 5 | 51 | 2 | IPR020615 | |
| Domain | Thiolase_C | 1.09e-04 | 6 | 51 | 2 | PF02803 | |
| Domain | Thiolase_N | 1.09e-04 | 6 | 51 | 2 | PF00108 | |
| Domain | THIOLASE_2 | 1.09e-04 | 6 | 51 | 2 | PS00737 | |
| Domain | THIOLASE_1 | 1.09e-04 | 6 | 51 | 2 | PS00098 | |
| Domain | THIOLASE_3 | 1.09e-04 | 6 | 51 | 2 | PS00099 | |
| Domain | Thiolase_N | 1.09e-04 | 6 | 51 | 2 | IPR020616 | |
| Domain | Thiolase_C | 1.09e-04 | 6 | 51 | 2 | IPR020617 | |
| Domain | Thiolase_CS | 1.09e-04 | 6 | 51 | 2 | IPR020613 | |
| Domain | Thiolase | 1.09e-04 | 6 | 51 | 2 | IPR002155 | |
| Domain | NaH_exchanger | 2.60e-04 | 9 | 51 | 2 | IPR004709 | |
| Domain | - | 3.24e-04 | 10 | 51 | 2 | 3.40.47.10 | |
| Domain | Thiolase-like | 3.24e-04 | 10 | 51 | 2 | IPR016039 | |
| Domain | Cation/H_exchanger_CPA1 | 3.96e-04 | 11 | 51 | 2 | IPR018422 | |
| Domain | Na_H_Exchanger | 6.51e-04 | 14 | 51 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 6.51e-04 | 14 | 51 | 2 | IPR006153 | |
| Domain | IPT | 2.46e-03 | 27 | 51 | 2 | SM00429 | |
| Domain | TIG | 3.23e-03 | 31 | 51 | 2 | PF01833 | |
| Domain | IPT | 3.44e-03 | 32 | 51 | 2 | IPR002909 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 4.11e-03 | 35 | 51 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.83e-03 | 38 | 51 | 2 | PS00690 | |
| Pathway | KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION | 1.28e-06 | 23 | 51 | 4 | M4361 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.54e-06 | 55 | 51 | 5 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.84e-06 | 57 | 51 | 5 | MM15643 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 7.32e-06 | 35 | 51 | 4 | MM17219 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 1.14e-05 | 39 | 51 | 4 | MM17212 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.26e-05 | 84 | 51 | 5 | MM14653 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 1.54e-05 | 42 | 51 | 4 | M16473 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 1.85e-05 | 154 | 51 | 6 | M39007 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 2.03e-05 | 45 | 51 | 4 | MM14912 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.14e-05 | 158 | 51 | 6 | MM14812 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.63e-05 | 48 | 51 | 4 | MM17214 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 3.90e-05 | 53 | 51 | 4 | MM15716 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.20e-05 | 54 | 51 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.20e-05 | 54 | 51 | 4 | MM15202 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 4.20e-05 | 54 | 51 | 4 | MM14655 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.86e-05 | 56 | 51 | 4 | MM14815 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 5.58e-05 | 58 | 51 | 4 | MM14914 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 6.38e-05 | 60 | 51 | 4 | MM14913 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 6.38e-05 | 60 | 51 | 4 | MM14872 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 7.51e-05 | 23 | 51 | 3 | M1926 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 7.51e-05 | 23 | 51 | 3 | MM14741 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.23e-04 | 135 | 51 | 5 | MM14781 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.87e-04 | 79 | 51 | 4 | M17673 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.25e-04 | 33 | 51 | 3 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.25e-04 | 33 | 51 | 3 | MM14737 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A9 SLC9A2 ATP7B SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC7A10 SLC47A2 | 2.58e-04 | 736 | 51 | 10 | M27287 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.23e-04 | 176 | 51 | 5 | MM15718 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 4.55e-04 | 9 | 51 | 2 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 4.55e-04 | 9 | 51 | 2 | MM15079 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.05e-04 | 183 | 51 | 5 | M997 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.16e-04 | 103 | 51 | 4 | MM15196 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 5.32e-04 | 44 | 51 | 3 | M499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION | 5.67e-04 | 10 | 51 | 2 | M47635 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 5.69e-04 | 45 | 51 | 3 | MM14751 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 5.96e-04 | 107 | 51 | 4 | MM14915 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.17e-04 | 108 | 51 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.39e-04 | 109 | 51 | 4 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A9 SLC9A2 ATP7B SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC7A10 | 6.67e-04 | 681 | 51 | 9 | MM14985 |
| Pathway | KEGG_MEDICUS_REFERENCE_BETA_OXIDATION | 6.91e-04 | 11 | 51 | 2 | M47630 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 7.56e-04 | 114 | 51 | 4 | MM14814 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.14e-03 | 14 | 51 | 2 | M27074 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.14e-03 | 14 | 51 | 2 | MM14748 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.23e-03 | 130 | 51 | 4 | M27454 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 1.27e-03 | 131 | 51 | 4 | MM15717 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | 1.44e-03 | 471 | 51 | 7 | M39009 | |
| Pathway | KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS | 1.49e-03 | 16 | 51 | 2 | M3214 | |
| Pathway | REACTOME_PEROXISOMAL_PROTEIN_IMPORT | 1.66e-03 | 65 | 51 | 3 | MM15628 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 1.89e-03 | 18 | 51 | 2 | M4862 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.00e-03 | 249 | 51 | 5 | M5988 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 2.09e-03 | 150 | 51 | 4 | MM14889 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 2.11e-03 | 19 | 51 | 2 | MM14612 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.95e-03 | 165 | 51 | 4 | MM15026 | |
| Pubmed | 8.56e-12 | 4 | 61 | 4 | 21849490 | ||
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 4.28e-11 | 5 | 61 | 4 | 3035563 | |
| Pubmed | 1.28e-10 | 6 | 61 | 4 | 3036582 | ||
| Pubmed | Differential involvement of Na(+),K(+)-ATPase isozymes in preimplantation development of the mouse. | 2.98e-10 | 7 | 61 | 4 | 10837135 | |
| Pubmed | 2.98e-10 | 7 | 61 | 4 | 2158121 | ||
| Pubmed | 1.61e-09 | 29 | 61 | 5 | 15071553 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 2822726 | ||
| Pubmed | Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes. | 5.13e-09 | 3 | 61 | 3 | 30819023 | |
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 5.13e-09 | 3 | 61 | 3 | 26373354 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 17947306 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 19058785 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 28465228 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 8203495 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 18044013 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 26911348 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 25994790 | ||
| Pubmed | 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. | 1.15e-08 | 15 | 61 | 4 | 12657787 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 21731499 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 12458206 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 17446412 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 19751721 | ||
| Pubmed | Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. | 2.05e-08 | 4 | 61 | 3 | 19376779 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 17234593 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 2887455 | ||
| Pubmed | Ouabain inhibits tubuloglomerular feedback in mutant mice with ouabain-sensitive alpha1 Na,K-ATPase. | 5.12e-08 | 5 | 61 | 3 | 16870707 | |
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 6.12e-08 | 22 | 61 | 4 | 2499654 | |
| Pubmed | Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. | 1.02e-07 | 6 | 61 | 3 | 10636900 | |
| Pubmed | Expression and distribution of Na, K-ATPase isoforms in the human uterus. | 1.79e-07 | 7 | 61 | 3 | 20065300 | |
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 19683723 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 2885848 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 23652595 | ||
| Pubmed | 4.28e-07 | 9 | 61 | 3 | 15253893 | ||
| Pubmed | Retinal pigment epithelial integrity is compromised in the developing albino mouse retina. | 1.12e-06 | 12 | 61 | 3 | 27097562 | |
| Pubmed | 1.52e-06 | 202 | 61 | 6 | 24639526 | ||
| Pubmed | 1.84e-06 | 14 | 61 | 3 | 1572638 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15781423 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15473316 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21498719 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 6324196 | ||
| Pubmed | Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase. | 3.03e-06 | 2 | 61 | 2 | 19376809 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 35446892 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 14742675 | ||
| Pubmed | ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. | 3.03e-06 | 2 | 61 | 2 | 33880529 | |
| Pubmed | Alternative transcription initiation and splicing variants of the DHRS4 gene cluster. | 3.03e-06 | 2 | 61 | 2 | 18754758 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17230527 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11507009 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10555956 | ||
| Pubmed | The structure of the Na+,K+-ATPase and mapping of isoform differences and disease-related mutations. | 3.03e-06 | 2 | 61 | 2 | 18957371 | |
| Pubmed | All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. | 3.03e-06 | 2 | 61 | 2 | 11546672 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24391932 | ||
| Pubmed | DOCA-salt hypertension does not require the ouabain-sensitive binding site of the α2 Na,K-ATPase. | 3.03e-06 | 2 | 61 | 2 | 22258333 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22739122 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10360172 | ||
| Pubmed | Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons. | 3.03e-06 | 2 | 61 | 2 | 23761886 | |
| Pubmed | Ion pumps in polarized cells: sorting and regulation of the Na+, K+- and H+, K+-ATPases. | 3.03e-06 | 2 | 61 | 2 | 11404365 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20952666 | ||
| Pubmed | The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit. | 3.03e-06 | 2 | 61 | 2 | 3030810 | |
| Pubmed | Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load. | 3.03e-06 | 2 | 61 | 2 | 18667729 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21632957 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24356962 | ||
| Pubmed | Expression of alpha isoforms of the Na,K-ATPase in human heart. | 3.03e-06 | 2 | 61 | 2 | 8391840 | |
| Pubmed | 3.43e-06 | 17 | 61 | 3 | 36230906 | ||
| Pubmed | 4.88e-06 | 19 | 61 | 3 | 20861386 | ||
| Pubmed | 5.60e-06 | 144 | 61 | 5 | 35681168 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 11557593 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 25033048 | ||
| Pubmed | Isoform specificity of the Na/K-ATPase association and regulation by phospholemman. | 9.07e-06 | 3 | 61 | 2 | 19638348 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 27323117 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21094218 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 14685860 | ||
| Pubmed | In situ localization of sodium-potassium ATPase mRNA in developing mouse lung epithelium. | 9.07e-06 | 3 | 61 | 2 | 7573462 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 10333503 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 27836549 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 20525226 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 9159180 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 12680773 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 33544780 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 15383549 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18052210 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 22565168 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 14627611 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 26988030 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 15485817 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 12477859 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 16243970 | ||
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 1.05e-05 | 77 | 61 | 4 | 15608191 | |
| Pubmed | Subunit isoform selectivity in assembly of Na,K-ATPase α-β heterodimers. | 1.81e-05 | 4 | 61 | 2 | 22696220 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 16406282 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 16861705 | ||
| Pubmed | Na,K-ATPase expression in the mouse cochlea is not dependent on the mineralocorticoid receptor. | 1.81e-05 | 4 | 61 | 2 | 11591489 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 19570895 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 23224879 | ||
| Pubmed | Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes. | 1.81e-05 | 4 | 61 | 2 | 23036705 | |
| Pubmed | Chromosomal localization of human Na+, K+-ATPase alpha- and beta-subunit genes. | 2.02e-05 | 30 | 61 | 3 | 2842249 | |
| Pubmed | The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. | 2.04e-05 | 91 | 61 | 4 | 9841928 | |
| Pubmed | 2.54e-05 | 331 | 61 | 6 | 29199018 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 17804407 | ||
| Pubmed | Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium ATPase genes. | 3.02e-05 | 5 | 61 | 2 | 16430714 | |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 32293933 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 16292983 | ||
| Cytoband | 14q32.33 | 5.62e-07 | 228 | 60 | 6 | 14q32.33 | |
| Cytoband | 2p23 | 2.26e-04 | 17 | 60 | 2 | 2p23 | |
| Cytoband | 12q24.13 | 4.94e-04 | 25 | 60 | 2 | 12q24.13 | |
| Cytoband | 1q23.2 | 9.72e-04 | 35 | 60 | 2 | 1q23.2 | |
| Cytoband | 14q11.2 | 1.72e-03 | 180 | 60 | 3 | 14q11.2 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.66e-09 | 7 | 49 | 4 | 1208 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-30-5 IGHV3-30-3 IGHV3-43D | 6.73e-07 | 187 | 49 | 7 | 349 |
| GeneFamily | Solute carriers | SLC9A9 SLC25A21 SLC9A2 SLC41A3 SLC17A1 SLC37A2 SLC7A10 SLC47A2 | 9.96e-06 | 395 | 49 | 8 | 752 |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 1.14e-03 | 76 | 49 | 3 | 743 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.33e-03 | 20 | 49 | 2 | 548 | |
| Coexpression | XU_CREBBP_TARGETS_DN | 1.43e-07 | 56 | 57 | 5 | MM642 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 4.81e-06 | 200 | 57 | 6 | M6652 | |
| Coexpression | BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES | 4.18e-05 | 177 | 57 | 5 | M40028 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 6.78e-05 | 196 | 57 | 5 | M6111 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 7.29e-05 | 102 | 57 | 4 | MM872 | |
| Coexpression | GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN | 7.46e-05 | 200 | 57 | 5 | M5124 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP | 7.46e-05 | 200 | 57 | 5 | M5997 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 194 | 58 | 6 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 143 | 58 | 5 | 0cd332c128710291a39957d3da22953352f5c382 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.64e-06 | 179 | 58 | 5 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Lypd1_(CA1_Principal_cells_(Anterior))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.44e-06 | 84 | 58 | 4 | 52d167614afa9b056f2934142d3250fe5e70e806 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 189 | 58 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | HSPCs-Ery_prog.|HSPCs / Lineage and Cell class | 4.75e-06 | 189 | 58 | 5 | 37d2c45debed1564a40a1085b8b310c50923b9e7 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 5.12e-06 | 192 | 58 | 5 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | HSPCs-Ery_prog.|World / Lineage and Cell class | 5.25e-06 | 193 | 58 | 5 | 484c2e0daedc6cb0d50d164add8c1658123a60f9 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 5.66e-06 | 196 | 58 | 5 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.81e-06 | 197 | 58 | 5 | 2662138671262b30508c5759038bcdcfe6551696 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.81e-06 | 197 | 58 | 5 | 76465bb2408c7c75f694e8f7cf1a606b796afc3a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-06 | 198 | 58 | 5 | 72733b6149b797ac11cc108bc80428b77fbbba78 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-06 | 198 | 58 | 5 | f23559ce6072e3c323f6791ff95269271b0f7ff1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-06 | 199 | 58 | 5 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 3.34e-05 | 140 | 58 | 4 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.53e-05 | 142 | 58 | 4 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 146 | 58 | 4 | 24e63124116b9a6796ae0495fc69dc6b6af28c38 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 146 | 58 | 4 | ae43d418492177546b7f85afffb4287d40815f88 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.73e-05 | 153 | 58 | 4 | 3570dd844d6479425bf6f62129f88efa45553775 | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|tumor_Lung / Location, Cell class and cell subclass | 5.91e-05 | 162 | 58 | 4 | 9ac3242511315224ed94582aca9e9a3786cd01a0 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-05 | 167 | 58 | 4 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.64e-05 | 167 | 58 | 4 | 820472887f43b42ae7e44513ca3d5465fb4f71a7 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-05 | 167 | 58 | 4 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.96e-05 | 169 | 58 | 4 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 169 | 58 | 4 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 169 | 58 | 4 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.62e-05 | 173 | 58 | 4 | 68bcc0eee15df9cf3516c641709154301bd7b38f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.62e-05 | 173 | 58 | 4 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 7.96e-05 | 175 | 58 | 4 | d73ee324479172501481b54967a0f3bd870fcf3a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-05 | 179 | 58 | 4 | ba7744b903abfc28b39a00472661f152e9ae39fd | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.88e-05 | 180 | 58 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.88e-05 | 180 | 58 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-05 | 181 | 58 | 4 | e47664a264a2c37390d1668ce04eef2e0172f4cb | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-05 | 181 | 58 | 4 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.07e-05 | 181 | 58 | 4 | 3457c1d431db4282be5a6243119e48960748ede7 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.07e-05 | 181 | 58 | 4 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 9.47e-05 | 183 | 58 | 4 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.47e-05 | 183 | 58 | 4 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 9.67e-05 | 184 | 58 | 4 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.87e-05 | 185 | 58 | 4 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 185 | 58 | 4 | 08bc817908076734d66f2805cb954141f2cc5a18 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 185 | 58 | 4 | 1704a12153a9b107bf03ecccd1a036cf61334d7a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 186 | 58 | 4 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 186 | 58 | 4 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 186 | 58 | 4 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 186 | 58 | 4 | 459a7e97bbac2b2cd253aa4ab38d0e4ae6191e8b | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 186 | 58 | 4 | cb4ea1bc1427230070e9696baeda7de241c354b1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 186 | 58 | 4 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 186 | 58 | 4 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 187 | 58 | 4 | db771e952f71a12886c2dbc77c6cd07054ef809a | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.05e-04 | 188 | 58 | 4 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 189 | 58 | 4 | a010f3e4da6e9bb23b0b9a7f82ad5cee4e607ecd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 189 | 58 | 4 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 189 | 58 | 4 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 189 | 58 | 4 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 190 | 58 | 4 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 190 | 58 | 4 | 3bd422755ce1d9854dbfebca7b28afa1d03d595c | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 190 | 58 | 4 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 191 | 58 | 4 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 191 | 58 | 4 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 191 | 58 | 4 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 191 | 58 | 4 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|Lymphoid / Condition, Lineage and Cell class | 1.12e-04 | 191 | 58 | 4 | bcdadf83cb9653f9cc2a281e7c1095fe8f79173c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 192 | 58 | 4 | 3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233 | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|COVID-19 / Condition, Lineage and Cell class | 1.16e-04 | 193 | 58 | 4 | bffd97a73365e1dd23ff3b0320b4860f04ec091a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 193 | 58 | 4 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 193 | 58 | 4 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 193 | 58 | 4 | 5c5543e7c83ecea44d23521246592c0301044173 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 193 | 58 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 193 | 58 | 4 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 193 | 58 | 4 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 194 | 58 | 4 | fa50c77a6d6b083cdafdb07243bc68b894977487 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 194 | 58 | 4 | fad22d5cf62016cad979e6943e357106d8d2a4b4 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 194 | 58 | 4 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 73 | 58 | 3 | 582faedb369a099d0acf1565413e6b3ca2cfc564 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.21e-04 | 195 | 58 | 4 | 1992a1673b7213e25f3c76ac77da35c57daceddd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 195 | 58 | 4 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 195 | 58 | 4 | 13f4ee21568fd747608412d33559d10561dbb3c8 | |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.21e-04 | 195 | 58 | 4 | d0305c6a68c9e361507b04db94f86873085d49b3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 195 | 58 | 4 | 3f517c6fc372bdcaf45b3af373414f13cbebd4ba | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|COVID-19_Severe / Disease condition and Cell class | 1.21e-04 | 195 | 58 | 4 | 787ea9f38ad8e2a836222ca97f4d927f7e79517d | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 195 | 58 | 4 | df009b18898c10686f75cf72b4ec0eff18f5bb50 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 196 | 58 | 4 | c38e7f533c619afe008de0e99042f7180c2da918 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 196 | 58 | 4 | b2aee2f67da373a10b0c25e7797e30e3811543a8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 196 | 58 | 4 | fc67d8aad1ec4d7f98ffe44fb103e230b9b42c35 | |
| ToppCell | Mild|World / Disease group and Cell class | 1.23e-04 | 196 | 58 | 4 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 196 | 58 | 4 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.23e-04 | 196 | 58 | 4 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.23e-04 | 196 | 58 | 4 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 1.23e-04 | 196 | 58 | 4 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 1.23e-04 | 196 | 58 | 4 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 196 | 58 | 4 | fec21383435779bf4c632decd3d29c6ca7baebfb | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-04 | 197 | 58 | 4 | 88b29d205237f07a9a26cc15a1cf4ed4816a4c4b | |
| ToppCell | Biopsy_Control_(H.)-Immune-Plasma_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.26e-04 | 197 | 58 | 4 | 275f38ed7e477000e864cecf9b7d49ae134c3b6a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 197 | 58 | 4 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.26e-04 | 197 | 58 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.26e-04 | 197 | 58 | 4 | 5bf4d964a9ee82002d3bc9ba1f020902eb96de7a | |
| Computational | Genes in the cancer module 249. | 5.09e-05 | 22 | 36 | 3 | MODULE_249 | |
| Drug | 22,23-dihydrobufalin | 1.26e-07 | 5 | 54 | 3 | CID000195392 | |
| Drug | 3-acetylstrophanthin | 1.26e-07 | 5 | 54 | 3 | CID003082282 | |
| Drug | thevetin A | 1.26e-07 | 5 | 54 | 3 | CID000441873 | |
| Drug | amyl nitrite | 1.63e-07 | 53 | 54 | 5 | CID000008053 | |
| Drug | ETH157 | 2.51e-07 | 6 | 54 | 3 | CID000563154 | |
| Drug | dihydrodigitoxigenin | 4.38e-07 | 7 | 54 | 3 | CID000107549 | |
| Drug | bumetanide | 6.10e-07 | 209 | 54 | 7 | CID000002471 | |
| Drug | R-TrHOCCoA | 1.05e-06 | 9 | 54 | 3 | CID000440690 | |
| Drug | AC1L99QU | 1.05e-06 | 9 | 54 | 3 | CID000440676 | |
| Drug | trimethaphan | 1.39e-06 | 81 | 54 | 5 | CID000023576 | |
| Drug | sodium | CA12 SLC9A9 SLC9A2 DHRS4 ATP7B MOCS3 SLC17A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 SLC7A10 | 1.65e-06 | 944 | 54 | 12 | CID000000923 |
| Drug | ouabagenin | 2.05e-06 | 11 | 54 | 3 | CID000010497 | |
| Drug | poly(vinylidene fluoride | 2.22e-06 | 89 | 54 | 5 | CID000006369 | |
| Drug | A-32686 | 3.55e-06 | 13 | 54 | 3 | CID000004951 | |
| Drug | AC1L99R9 | 4.51e-06 | 14 | 54 | 3 | CID000440685 | |
| Drug | HDMA | 8.38e-06 | 17 | 54 | 3 | CID000131092 | |
| Drug | acetylstrophanthidin | 1.00e-05 | 18 | 54 | 3 | CID000006062 | |
| Drug | AC1L1F3Q | 1.00e-05 | 18 | 54 | 3 | CID000003068 | |
| Drug | NSC 234205 | 1.00e-05 | 18 | 54 | 3 | CID000010104 | |
| Drug | sodium iodide | 1.17e-05 | 59 | 54 | 4 | CID000005238 | |
| Drug | Cymarigenen | 1.40e-05 | 20 | 54 | 3 | CID000005303 | |
| Drug | AC1NST54 | 1.63e-05 | 21 | 54 | 3 | CID005315525 | |
| Drug | levulinic acid | 1.65e-05 | 3 | 54 | 2 | CID000011578 | |
| Drug | NSC9567 | 2.10e-05 | 141 | 54 | 5 | CID000003001 | |
| Drug | cardenolide | 2.16e-05 | 23 | 54 | 3 | CID000016142 | |
| Drug | hydride | CA12 HSD3B7 SLC9A9 SLC9A2 DHRS4 SLC17A1 HADHB ATP1A2 ATP1A3 SLC47A2 | 2.31e-05 | 835 | 54 | 10 | CID000000783 |
| Drug | AC1L1947 | 3.15e-05 | 26 | 54 | 3 | CID000000383 | |
| Drug | AS701 | 3.30e-05 | 4 | 54 | 2 | CID000133528 | |
| Drug | AC1L4X7Z | 3.30e-05 | 4 | 54 | 2 | CID000193896 | |
| Drug | Benazepril-d5 | 3.36e-05 | 77 | 54 | 4 | CID000002311 | |
| Drug | Amiloride | 3.54e-05 | 78 | 54 | 4 | ctd:D000584 | |
| Drug | furosemide | 4.39e-05 | 272 | 54 | 6 | CID000003440 | |
| Drug | nalidixic acid | 4.86e-05 | 277 | 54 | 6 | CID000004421 | |
| Drug | glycine | 5.00e-05 | 169 | 54 | 5 | CID000000750 | |
| Drug | 2-chloro-6-phenylhexanoate | 5.50e-05 | 5 | 54 | 2 | CID000195566 | |
| Drug | Fr 6 | 5.50e-05 | 5 | 54 | 2 | CID000449013 | |
| Drug | AC1L8Y60 | 5.94e-05 | 89 | 54 | 4 | CID000410009 | |
| Drug | 2-methylacetoacetate | 8.23e-05 | 6 | 54 | 2 | CID000150996 | |
| Drug | 4-hydroxyvalerate | 8.23e-05 | 6 | 54 | 2 | CID000114539 | |
| Drug | sodium; lithium | 8.52e-05 | 36 | 54 | 3 | CID012725854 | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; HL60; HT_HG-U133A | 9.61e-05 | 194 | 54 | 5 | 3021_DN | |
| Drug | Diazoxide [364-98-7]; Up 200; 17.4uM; PC3; HT_HG-U133A | 1.01e-04 | 196 | 54 | 5 | 2052_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 54 | 5 | 1242_DN | |
| Drug | dihydropyrone | 1.15e-04 | 7 | 54 | 2 | CID000010760 | |
| Drug | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine | 1.15e-04 | 7 | 54 | 2 | ctd:C481648 | |
| Drug | (E)-heptadec-2-enoic acid | 1.15e-04 | 7 | 54 | 2 | CID005282747 | |
| Drug | Nsc638719 | 1.15e-04 | 7 | 54 | 2 | CID005459174 | |
| Drug | CID6432277 | 1.26e-04 | 41 | 54 | 3 | CID006432277 | |
| Drug | glutaconyl-CoA | 1.53e-04 | 8 | 54 | 2 | CID009543049 | |
| Drug | 3alpha, 7alpha-dihydroxy-5beta-cholestanoyl-CoA | 1.53e-04 | 8 | 54 | 2 | CID000440420 | |
| Drug | AC1MI0E8 | 1.53e-04 | 8 | 54 | 2 | CID003036008 | |
| Drug | Hydroflumethiazide | 1.53e-04 | 8 | 54 | 2 | DB00774 | |
| Drug | phenidone | 1.78e-04 | 46 | 54 | 3 | CID000007090 | |
| Drug | Digoxin | 1.78e-04 | 46 | 54 | 3 | ctd:D004077 | |
| Drug | Ouabain | 1.83e-04 | 119 | 54 | 4 | ctd:D010042 | |
| Drug | AC1MBZB6 | 1.97e-04 | 9 | 54 | 2 | CID002733620 | |
| Drug | 3-oxo-octanoyl-coenzyme A | 1.97e-04 | 9 | 54 | 2 | CID000440608 | |
| Drug | AC1L99M9 | 1.97e-04 | 9 | 54 | 2 | CID000440604 | |
| Drug | AC1L99MF | 1.97e-04 | 9 | 54 | 2 | CID000440606 | |
| Drug | Ammonia | 2.02e-04 | 48 | 54 | 3 | ctd:D000641 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 2.21e-04 | 125 | 54 | 4 | CID000002603 | |
| Drug | 6-methyluracil | 2.45e-04 | 10 | 54 | 2 | CID000012283 | |
| Drug | 2-Methylacetoacetyl-CoA | 2.45e-04 | 10 | 54 | 2 | CID000000053 | |
| Drug | 2-bromododecanoate | 2.45e-04 | 10 | 54 | 2 | CID000066980 | |
| Drug | hydroxyl radicals | CA12 SDSL HSD3B7 EEF2 PDPR ATP7B BAAT HADHB ATP1A1 ATP1A2 ATP1A3 | 2.61e-04 | 1341 | 54 | 11 | CID000000961 |
| Drug | Metribolone | 2.81e-04 | 382 | 54 | 6 | ctd:D015741 | |
| Drug | CGP-37157 | 3.00e-04 | 11 | 54 | 2 | CID000002688 | |
| Drug | 3-hydroxyhexanoate | 3.00e-04 | 11 | 54 | 2 | CID000151492 | |
| Drug | AC1L9LQQ | 3.37e-04 | 57 | 54 | 3 | CID000448224 | |
| Drug | NSC89595 | 3.37e-04 | 57 | 54 | 3 | CID000002464 | |
| Drug | dibutyryl cyclic 3',5'-AMP | 3.45e-04 | 561 | 54 | 7 | CID000002460 | |
| Drug | hydroflumethiazide | 3.59e-04 | 12 | 54 | 2 | CID000003647 | |
| Drug | nilic acid | 3.59e-04 | 12 | 54 | 2 | CID000160471 | |
| Drug | 3-ketohexanoyl-CoA | 3.59e-04 | 12 | 54 | 2 | CID000440610 | |
| Drug | rubidium | 4.12e-04 | 61 | 54 | 3 | CID000105153 | |
| Drug | 3-chloropropionyl-CoA | 4.24e-04 | 13 | 54 | 2 | CID000125892 | |
| Drug | C22:0 | 4.24e-04 | 13 | 54 | 2 | CID000008215 | |
| Drug | poly(3-hydroxybutyrate-co-3-hydroxyvalerate | 4.24e-04 | 13 | 54 | 2 | CID000107801 | |
| Drug | AC1L1GU8 | 4.32e-04 | 62 | 54 | 3 | CID000003843 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 3.49e-10 | 7 | 54 | 4 | DOID:0060178 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 4.90e-09 | 12 | 54 | 4 | DOID:863 (implicated_via_orthology) | |
| Disease | abdominal adipose tissue measurement | 2.74e-06 | 53 | 54 | 4 | EFO_0803316 | |
| Disease | ALTERNATING HEMIPLEGIA OF CHILDHOOD 1 | 3.29e-06 | 2 | 54 | 2 | C3549447 | |
| Disease | alternating hemiplegia of childhood (is_implicated_in) | 3.29e-06 | 2 | 54 | 2 | DOID:0050635 (is_implicated_in) | |
| Disease | Alternating hemiplegia of childhood | 1.97e-05 | 4 | 54 | 2 | C0338488 | |
| Disease | cups of coffee per day measurement | 5.46e-05 | 40 | 54 | 3 | EFO_0006782 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 9.14e-05 | 8 | 54 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 1.47e-04 | 10 | 54 | 2 | EFO_0008321 | |
| Disease | N-acetylhistidine measurement | 1.79e-04 | 11 | 54 | 2 | EFO_0800022 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 2.14e-04 | 12 | 54 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | hyperhomocysteinemia (biomarker_via_orthology) | 2.14e-04 | 12 | 54 | 2 | DOID:9279 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.29e-04 | 163 | 54 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 2.44e-04 | 66 | 54 | 3 | DOID:3459 (is_marker_for) | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 2.53e-04 | 13 | 54 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 3.40e-04 | 15 | 54 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 3.86e-04 | 525 | 54 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.86e-04 | 525 | 54 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 3.94e-04 | 527 | 54 | 6 | C1458155 | |
| Disease | Breast Carcinoma | 4.40e-04 | 538 | 54 | 6 | C0678222 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.52e-04 | 195 | 54 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Bone marrow hypocellularity | 4.94e-04 | 18 | 54 | 2 | C1855710 | |
| Disease | monocyte count | TNFSF10 HLA-DRA NCOA1 ATP1A1 ATP1A3 ATP1A4 JAML SLC7A10 PARP12 | 6.03e-04 | 1320 | 54 | 9 | EFO_0005091 |
| Disease | Degenerative polyarthritis | 6.69e-04 | 93 | 54 | 3 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 6.69e-04 | 93 | 54 | 3 | C0086743 | |
| Disease | Neoplasm Metastasis | 6.75e-04 | 217 | 54 | 4 | C0027627 | |
| Disease | colon adenocarcinoma (is_marker_for) | 9.60e-04 | 25 | 54 | 2 | DOID:234 (is_marker_for) | |
| Disease | Fanconi Anemia | 9.60e-04 | 25 | 54 | 2 | C0015625 | |
| Disease | Pancytopenia | 1.04e-03 | 26 | 54 | 2 | C0030312 | |
| Disease | Acute monocytic leukemia | 1.04e-03 | 26 | 54 | 2 | C0023465 | |
| Disease | Miller Dieker syndrome | 1.29e-03 | 29 | 54 | 2 | C0265219 | |
| Disease | chloride measurement | 1.29e-03 | 29 | 54 | 2 | EFO_0009284 | |
| Disease | adult onset asthma | 1.33e-03 | 118 | 54 | 3 | EFO_1002011 | |
| Disease | Abnormality of radial ray | 1.67e-03 | 33 | 54 | 2 | C4228778 | |
| Disease | bullous pemphigoid | 1.78e-03 | 34 | 54 | 2 | EFO_0007187 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSGVGVVSVCQGVQI | 226 | Q14032 | |
| CTIIIGNIIGSGIFI | 46 | Q9NS82 | |
| LVVICVTGSQSEGHG | 71 | P07307 | |
| GQTAILVAIDGVLCG | 1176 | P35670 | |
| VQGTRNVIEACVQTG | 106 | Q9H2F3 | |
| AIGVCAQVVGVGCVL | 111 | O95388 | |
| LQGEGLSVTGTVCHV | 76 | Q9BTZ2 | |
| TTGVGLIASGQCDVI | 146 | P55084 | |
| LIASGQCDVIVAGGV | 151 | P55084 | |
| TCQALGEQVIALSVG | 711 | Q8TEM1 | |
| QIVAGGSAGLVEICL | 16 | Q9BQT8 | |
| LQGEGLSVTGTVCHV | 76 | Q6PKH6 | |
| NCQTGGVIAEILRGV | 111 | O00567 | |
| GVQCEVQLVESGGVV | 16 | P0DP04 | |
| GVQCQVQLVESGGGV | 16 | P0DP03 | |
| TVLGIIFTNGNCVAE | 206 | Q96LZ2 | |
| FVVGAVGNGLTCLVI | 71 | Q9HB89 | |
| GVQCQVQLVESGGGV | 16 | P0DP02 | |
| IVEGCQRQGAIVAVT | 701 | P05023 | |
| GQSVGVQGEAACVSI | 451 | Q9NYF5 | |
| GIQQGIIEGEFAICI | 351 | Q8IYD8 | |
| QVQVCTAAGLSLGII | 291 | O43570 | |
| TQAQVVICGGGITGT | 41 | Q8NCN5 | |
| GVIQGGALSSICTQI | 1886 | Q8TDM6 | |
| GVQCEVQLVESGGGV | 16 | A0A0C4DH32 | |
| VCLVGFVGNLCVIGI | 46 | Q8TDV0 | |
| GVQCEVQLVESGGVV | 16 | A0A0B4J1X8 | |
| VVGEVTQVLCAAGGA | 6 | Q9H0J9 | |
| VGALLLSVCQTVSQG | 676 | Q9BX63 | |
| FVVIQVCNGLVQTTG | 146 | Q8TED4 | |
| NCVEGTARGIVIATG | 246 | P50993 | |
| CLSVVIFGTGIIGNL | 266 | O15354 | |
| GVGISNTGICVADTV | 801 | P01031 | |
| ENVVCALGLTVGLVG | 216 | P01903 | |
| GVQCQVQLVESGGGV | 16 | P01768 | |
| IVEGCQRQGAIVAVT | 691 | P13637 | |
| CGNIVGLVGVDQFLV | 466 | P13639 | |
| RVIGAVGIGIACVQV | 221 | P48509 | |
| VTCGIGVREVILTNG | 86 | Q9HBV2 | |
| GVVTGVLGCLQALEV | 246 | O95396 | |
| GVQCQVQLVESGGGV | 16 | P01772 | |
| STQQGGLIVGIIRCV | 561 | Q9Y2J0 | |
| FVNVCGVSVGVGLSS | 76 | Q86VL8 | |
| GLTGIVAVLFCGVTQ | 331 | Q8IVB4 | |
| FQVIAVDGVCTGIIQ | 231 | Q9NSN8 | |
| GGNQLVIIVGIVCAT | 271 | Q86YT9 | |
| QVFADVQCTVNLVGG | 1391 | Q15788 | |
| VVVCRAVQGAAQGIV | 136 | Q14916 | |
| VICGVGGNLVAIQTS | 321 | Q96GZ6 | |
| VIITAVTENFGCLGG | 1736 | P08F94 | |
| LTSVVVIVCGGNNIN | 301 | Q96GA7 | |
| NCVEGTARGIVIATG | 256 | Q13733 | |
| VGSGTCITQVGQQLF | 41 | Q6NUJ2 | |
| ACIGGGQGIAVIIQS | 381 | P42765 | |
| SIGIGVSLFGICQIE | 181 | Q9UBY0 | |
| VVTTQVELGGCSRQG | 31 | Q5MJ68 | |
| VLCGIQLVNATIGVF | 171 | O14894 | |
| VQGGPSLGQTCVLIV | 6 | P50591 | |
| GFVLTQVQGGAIICG | 1736 | P01266 | |
| GLGAVADCVGINVTV | 886 | Q04912 | |
| NSVVICDGLGQVVGE | 656 | Q9BRZ2 | |
| GINQATLSGCIDVIV | 21 | Q92539 |